Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease

This is a preview of subscription content, access via your institution

Access options

Buy this article

Purchase on Springer Link

Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Soubani AO, Chandrasekar PH . The clinical spectrum of pulmonary aspergillosis. Chest 2002; 121: 1988–1999.

    Article  Google Scholar 

  2. Gonzalez CE, Rinaldi MG, Sugar AM . Zygomycosis. Infect Dis Clin North Am 2002; 16: 895–914.

    Article  Google Scholar 

  3. Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347: 408–415.

    Article  CAS  Google Scholar 

  4. Mora-Duarte J, Betts R, Rotstein C et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002; 347: 2020–2029.

    Article  CAS  Google Scholar 

  5. Mehta J . Do variations in molecular structure affect the clinical efficacy and safety of lipid-based amphotericin B preparations? Leuk Res 1997; 21: 183–188.

    Article  CAS  Google Scholar 

  6. Mehta J, Kelsey SM, Chu P et al. Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies. Bone Marrow Transplant 1997; 20: 39–43.

    Article  CAS  Google Scholar 

  7. Matot I, Pizov R . Pulmonary extraction and accumulation of lipid formulations of amphotericin B. Crit Care Med 2000; 28: 2528–2532.

    Article  CAS  Google Scholar 

  8. Dannaoui E, Afeltra J, Meis JFGM et al. In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents. Antimicrob Agents Chemother 2002; 46: 2708–2711.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verma, A., Williams, S., Trifilio, S. et al. Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease. Bone Marrow Transplant 33, 1065–1066 (2004). https://doi.org/10.1038/sj.bmt.1704485

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704485

This article is cited by

Search

Quick links